Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase
Conditions
- Extensive-stage Small Cell Lung Cancer (ES-SCLC)
- The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative Therapy
Interventions
- DRUG: Nano-crystalline Megestrol Acetate Oral Suspension
- DRUG: standard treatment
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Collaborators